nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—MAOA—locus ceruleus—Alzheimer's disease	0.0267	0.141	CbGeAlD
Rizatriptan—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0172	0.0908	CbGeAlD
Rizatriptan—HTR1D—telencephalic ventricle—Alzheimer's disease	0.0166	0.0879	CbGeAlD
Rizatriptan—HTR1A—telencephalic ventricle—Alzheimer's disease	0.0139	0.0733	CbGeAlD
Rizatriptan—HTR1F—forebrain—Alzheimer's disease	0.011	0.0579	CbGeAlD
Rizatriptan—HTR1F—telencephalon—Alzheimer's disease	0.0101	0.0532	CbGeAlD
Rizatriptan—HTR1B—blood vessel—Alzheimer's disease	0.00851	0.0449	CbGeAlD
Rizatriptan—HTR1D—blood vessel—Alzheimer's disease	0.00824	0.0435	CbGeAlD
Rizatriptan—Melatonin—MT3—Alzheimer's disease	0.00666	0.476	CrCbGaD
Rizatriptan—HTR1F—nervous system—Alzheimer's disease	0.00595	0.0314	CbGeAlD
Rizatriptan—HTR1F—central nervous system—Alzheimer's disease	0.00573	0.0302	CbGeAlD
Rizatriptan—HTR1F—brain—Alzheimer's disease	0.00455	0.024	CbGeAlD
Rizatriptan—HTR1B—forebrain—Alzheimer's disease	0.00449	0.0237	CbGeAlD
Rizatriptan—HTR1D—forebrain—Alzheimer's disease	0.00435	0.023	CbGeAlD
Rizatriptan—HTR1B—telencephalon—Alzheimer's disease	0.00413	0.0218	CbGeAlD
Rizatriptan—HTR1D—telencephalon—Alzheimer's disease	0.004	0.0211	CbGeAlD
Rizatriptan—MAOA—embryo—Alzheimer's disease	0.00374	0.0198	CbGeAlD
Rizatriptan—HTR1A—forebrain—Alzheimer's disease	0.00362	0.0191	CbGeAlD
Rizatriptan—HTR1A—telencephalon—Alzheimer's disease	0.00333	0.0176	CbGeAlD
Rizatriptan—MAOA—forebrain—Alzheimer's disease	0.00331	0.0175	CbGeAlD
Rizatriptan—Melatonin—CALM1—Alzheimer's disease	0.00317	0.227	CrCbGaD
Rizatriptan—MAOA—telencephalon—Alzheimer's disease	0.00304	0.0161	CbGeAlD
Rizatriptan—HTR1B—nervous system—Alzheimer's disease	0.00244	0.0129	CbGeAlD
Rizatriptan—HTR1D—nervous system—Alzheimer's disease	0.00236	0.0125	CbGeAlD
Rizatriptan—HTR1B—central nervous system—Alzheimer's disease	0.00235	0.0124	CbGeAlD
Rizatriptan—HTR1D—central nervous system—Alzheimer's disease	0.00227	0.012	CbGeAlD
Rizatriptan—HTR1A—nervous system—Alzheimer's disease	0.00197	0.0104	CbGeAlD
Rizatriptan—HTR1A—central nervous system—Alzheimer's disease	0.00189	0.01	CbGeAlD
Rizatriptan—HTR1B—brain—Alzheimer's disease	0.00186	0.00984	CbGeAlD
Rizatriptan—HTR1A—cerebellum—Alzheimer's disease	0.00185	0.00978	CbGeAlD
Rizatriptan—HTR1D—brain—Alzheimer's disease	0.0018	0.00953	CbGeAlD
Rizatriptan—MAOA—nervous system—Alzheimer's disease	0.0018	0.00949	CbGeAlD
Rizatriptan—MAOA—central nervous system—Alzheimer's disease	0.00173	0.00914	CbGeAlD
Rizatriptan—Melatonin—MPO—Alzheimer's disease	0.00173	0.123	CrCbGaD
Rizatriptan—MAOA—cerebellum—Alzheimer's disease	0.00169	0.00893	CbGeAlD
Rizatriptan—HTR1A—brain—Alzheimer's disease	0.0015	0.00794	CbGeAlD
Rizatriptan—Muscle spasms—Galantamine—Alzheimer's disease	0.0014	0.00263	CcSEcCtD
Rizatriptan—Sweating—Donepezil—Alzheimer's disease	0.00139	0.0026	CcSEcCtD
Rizatriptan—Dysuria—Memantine—Alzheimer's disease	0.00138	0.00258	CcSEcCtD
Rizatriptan—Vision blurred—Galantamine—Alzheimer's disease	0.00137	0.00258	CcSEcCtD
Rizatriptan—MAOA—brain—Alzheimer's disease	0.00137	0.00725	CbGeAlD
Rizatriptan—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00137	0.00257	CcSEcCtD
Rizatriptan—Tremor—Galantamine—Alzheimer's disease	0.00137	0.00256	CcSEcCtD
Rizatriptan—Epistaxis—Donepezil—Alzheimer's disease	0.00136	0.00256	CcSEcCtD
Rizatriptan—Pollakiuria—Memantine—Alzheimer's disease	0.00136	0.00255	CcSEcCtD
Rizatriptan—Dysuria—Rivastigmine—Alzheimer's disease	0.00135	0.00253	CcSEcCtD
Rizatriptan—Agitation—Galantamine—Alzheimer's disease	0.00134	0.00251	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00134	0.00251	CcSEcCtD
Rizatriptan—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00133	0.0025	CcSEcCtD
Rizatriptan—Bradycardia—Donepezil—Alzheimer's disease	0.00132	0.00248	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00132	0.00247	CcSEcCtD
Rizatriptan—Vertigo—Galantamine—Alzheimer's disease	0.00131	0.00246	CcSEcCtD
Rizatriptan—Syncope—Galantamine—Alzheimer's disease	0.00131	0.00245	CcSEcCtD
Rizatriptan—Melatonin—ESR1—Alzheimer's disease	0.00129	0.0925	CrCbGaD
Rizatriptan—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00129	0.00243	CcSEcCtD
Rizatriptan—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00129	0.00242	CcSEcCtD
Rizatriptan—Hallucination—Donepezil—Alzheimer's disease	0.00129	0.00242	CcSEcCtD
Rizatriptan—Palpitations—Galantamine—Alzheimer's disease	0.00129	0.00242	CcSEcCtD
Rizatriptan—Pharyngitis—Donepezil—Alzheimer's disease	0.00129	0.00242	CcSEcCtD
Rizatriptan—Myocardial infarction—Memantine—Alzheimer's disease	0.00129	0.00242	CcSEcCtD
Rizatriptan—Loss of consciousness—Galantamine—Alzheimer's disease	0.00128	0.00241	CcSEcCtD
Rizatriptan—Cough—Galantamine—Alzheimer's disease	0.00127	0.00239	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00127	0.00238	CcSEcCtD
Rizatriptan—Convulsion—Galantamine—Alzheimer's disease	0.00126	0.00237	CcSEcCtD
Rizatriptan—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00126	0.00236	CcSEcCtD
Rizatriptan—Hypertension—Galantamine—Alzheimer's disease	0.00126	0.00236	CcSEcCtD
Rizatriptan—Myalgia—Galantamine—Alzheimer's disease	0.00124	0.00233	CcSEcCtD
Rizatriptan—Chest pain—Galantamine—Alzheimer's disease	0.00124	0.00233	CcSEcCtD
Rizatriptan—Arthralgia—Galantamine—Alzheimer's disease	0.00124	0.00233	CcSEcCtD
Rizatriptan—Epistaxis—Memantine—Alzheimer's disease	0.00124	0.00232	CcSEcCtD
Rizatriptan—Anxiety—Galantamine—Alzheimer's disease	0.00124	0.00232	CcSEcCtD
Rizatriptan—Sweating—Rivastigmine—Alzheimer's disease	0.00123	0.00231	CcSEcCtD
Rizatriptan—Discomfort—Galantamine—Alzheimer's disease	0.00123	0.0023	CcSEcCtD
Rizatriptan—Dry mouth—Galantamine—Alzheimer's disease	0.00121	0.00228	CcSEcCtD
Rizatriptan—Epistaxis—Rivastigmine—Alzheimer's disease	0.00121	0.00227	CcSEcCtD
Rizatriptan—Tinnitus—Donepezil—Alzheimer's disease	0.00121	0.00227	CcSEcCtD
Rizatriptan—Confusional state—Galantamine—Alzheimer's disease	0.0012	0.00225	CcSEcCtD
Rizatriptan—Bradycardia—Memantine—Alzheimer's disease	0.0012	0.00225	CcSEcCtD
Rizatriptan—Bradycardia—Rivastigmine—Alzheimer's disease	0.00117	0.0022	CcSEcCtD
Rizatriptan—Hypoaesthesia—Memantine—Alzheimer's disease	0.00117	0.0022	CcSEcCtD
Rizatriptan—Hallucination—Memantine—Alzheimer's disease	0.00117	0.0022	CcSEcCtD
Rizatriptan—Shock—Galantamine—Alzheimer's disease	0.00117	0.0022	CcSEcCtD
Rizatriptan—Pharyngitis—Memantine—Alzheimer's disease	0.00117	0.0022	CcSEcCtD
Rizatriptan—Nervous system disorder—Galantamine—Alzheimer's disease	0.00117	0.00219	CcSEcCtD
Rizatriptan—Chills—Donepezil—Alzheimer's disease	0.00116	0.00219	CcSEcCtD
Rizatriptan—Tachycardia—Galantamine—Alzheimer's disease	0.00116	0.00218	CcSEcCtD
Rizatriptan—Arrhythmia—Donepezil—Alzheimer's disease	0.00116	0.00218	CcSEcCtD
Rizatriptan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00115	0.00216	CcSEcCtD
Rizatriptan—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00115	0.00215	CcSEcCtD
Rizatriptan—Hallucination—Rivastigmine—Alzheimer's disease	0.00115	0.00215	CcSEcCtD
Rizatriptan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00114	0.00215	CcSEcCtD
Rizatriptan—Almotriptan—CYP2D6—Alzheimer's disease	0.00114	0.0815	CrCbGaD
Rizatriptan—Mental disorder—Donepezil—Alzheimer's disease	0.00114	0.00213	CcSEcCtD
Rizatriptan—Anorexia—Galantamine—Alzheimer's disease	0.00113	0.00213	CcSEcCtD
Rizatriptan—Erythema—Donepezil—Alzheimer's disease	0.00113	0.00212	CcSEcCtD
Rizatriptan—Flatulence—Donepezil—Alzheimer's disease	0.00111	0.00209	CcSEcCtD
Rizatriptan—Tension—Donepezil—Alzheimer's disease	0.00111	0.00208	CcSEcCtD
Rizatriptan—Dysgeusia—Donepezil—Alzheimer's disease	0.00111	0.00208	CcSEcCtD
Rizatriptan—Tinnitus—Memantine—Alzheimer's disease	0.0011	0.00206	CcSEcCtD
Rizatriptan—Nervousness—Donepezil—Alzheimer's disease	0.0011	0.00206	CcSEcCtD
Rizatriptan—Flushing—Memantine—Alzheimer's disease	0.00109	0.00205	CcSEcCtD
Rizatriptan—Muscle spasms—Donepezil—Alzheimer's disease	0.00109	0.00204	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00108	0.00203	CcSEcCtD
Rizatriptan—Insomnia—Galantamine—Alzheimer's disease	0.00108	0.00202	CcSEcCtD
Rizatriptan—Tinnitus—Rivastigmine—Alzheimer's disease	0.00108	0.00202	CcSEcCtD
Rizatriptan—Flushing—Rivastigmine—Alzheimer's disease	0.00107	0.00201	CcSEcCtD
Rizatriptan—Angiopathy—Memantine—Alzheimer's disease	0.00107	0.00201	CcSEcCtD
Rizatriptan—Paraesthesia—Galantamine—Alzheimer's disease	0.00107	0.00201	CcSEcCtD
Rizatriptan—Vision blurred—Donepezil—Alzheimer's disease	0.00107	0.002	CcSEcCtD
Rizatriptan—Tremor—Donepezil—Alzheimer's disease	0.00106	0.00199	CcSEcCtD
Rizatriptan—Somnolence—Galantamine—Alzheimer's disease	0.00106	0.00199	CcSEcCtD
Rizatriptan—Chills—Memantine—Alzheimer's disease	0.00106	0.00198	CcSEcCtD
Rizatriptan—Arrhythmia—Memantine—Alzheimer's disease	0.00105	0.00198	CcSEcCtD
Rizatriptan—Dyspepsia—Galantamine—Alzheimer's disease	0.00105	0.00197	CcSEcCtD
Rizatriptan—Angiopathy—Rivastigmine—Alzheimer's disease	0.00105	0.00196	CcSEcCtD
Rizatriptan—Agitation—Donepezil—Alzheimer's disease	0.00104	0.00195	CcSEcCtD
Rizatriptan—Chills—Rivastigmine—Alzheimer's disease	0.00103	0.00194	CcSEcCtD
Rizatriptan—Decreased appetite—Galantamine—Alzheimer's disease	0.00103	0.00194	CcSEcCtD
Rizatriptan—Mental disorder—Memantine—Alzheimer's disease	0.00103	0.00194	CcSEcCtD
Rizatriptan—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00103	0.00193	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00103	0.00193	CcSEcCtD
Rizatriptan—Fatigue—Galantamine—Alzheimer's disease	0.00103	0.00193	CcSEcCtD
Rizatriptan—Constipation—Galantamine—Alzheimer's disease	0.00102	0.00191	CcSEcCtD
Rizatriptan—Vertigo—Donepezil—Alzheimer's disease	0.00102	0.00191	CcSEcCtD
Rizatriptan—Syncope—Donepezil—Alzheimer's disease	0.00101	0.0019	CcSEcCtD
Rizatriptan—Flatulence—Memantine—Alzheimer's disease	0.00101	0.0019	CcSEcCtD
Rizatriptan—Mental disorder—Rivastigmine—Alzheimer's disease	0.00101	0.0019	CcSEcCtD
Rizatriptan—Tension—Memantine—Alzheimer's disease	0.00101	0.00189	CcSEcCtD
Rizatriptan—Dysgeusia—Memantine—Alzheimer's disease	0.001	0.00189	CcSEcCtD
Rizatriptan—Erythema—Rivastigmine—Alzheimer's disease	0.001	0.00188	CcSEcCtD
Rizatriptan—Nervousness—Memantine—Alzheimer's disease	0.000997	0.00187	CcSEcCtD
Rizatriptan—Loss of consciousness—Donepezil—Alzheimer's disease	0.000993	0.00186	CcSEcCtD
Rizatriptan—Flatulence—Rivastigmine—Alzheimer's disease	0.000989	0.00186	CcSEcCtD
Rizatriptan—Cough—Donepezil—Alzheimer's disease	0.000986	0.00185	CcSEcCtD
Rizatriptan—Tension—Rivastigmine—Alzheimer's disease	0.000985	0.00185	CcSEcCtD
Rizatriptan—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000983	0.00184	CcSEcCtD
Rizatriptan—Feeling abnormal—Galantamine—Alzheimer's disease	0.000981	0.00184	CcSEcCtD
Rizatriptan—Convulsion—Donepezil—Alzheimer's disease	0.000979	0.00184	CcSEcCtD
Rizatriptan—Hypertension—Donepezil—Alzheimer's disease	0.000976	0.00183	CcSEcCtD
Rizatriptan—Nervousness—Rivastigmine—Alzheimer's disease	0.000975	0.00183	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000973	0.00183	CcSEcCtD
Rizatriptan—Vision blurred—Memantine—Alzheimer's disease	0.000967	0.00181	CcSEcCtD
Rizatriptan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000965	0.00181	CcSEcCtD
Rizatriptan—Myalgia—Donepezil—Alzheimer's disease	0.000962	0.00181	CcSEcCtD
Rizatriptan—Arthralgia—Donepezil—Alzheimer's disease	0.000962	0.00181	CcSEcCtD
Rizatriptan—Chest pain—Donepezil—Alzheimer's disease	0.000962	0.00181	CcSEcCtD
Rizatriptan—Tremor—Memantine—Alzheimer's disease	0.000961	0.0018	CcSEcCtD
Rizatriptan—Anxiety—Donepezil—Alzheimer's disease	0.000959	0.0018	CcSEcCtD
Rizatriptan—Discomfort—Donepezil—Alzheimer's disease	0.000951	0.00178	CcSEcCtD
Rizatriptan—Vision blurred—Rivastigmine—Alzheimer's disease	0.000946	0.00178	CcSEcCtD
Rizatriptan—Agitation—Memantine—Alzheimer's disease	0.000943	0.00177	CcSEcCtD
Rizatriptan—Dry mouth—Donepezil—Alzheimer's disease	0.000941	0.00177	CcSEcCtD
Rizatriptan—Abdominal pain—Galantamine—Alzheimer's disease	0.000941	0.00177	CcSEcCtD
Rizatriptan—Body temperature increased—Galantamine—Alzheimer's disease	0.000941	0.00177	CcSEcCtD
Rizatriptan—Tremor—Rivastigmine—Alzheimer's disease	0.000941	0.00176	CcSEcCtD
Rizatriptan—Confusional state—Donepezil—Alzheimer's disease	0.00093	0.00175	CcSEcCtD
Rizatriptan—Agitation—Rivastigmine—Alzheimer's disease	0.000923	0.00173	CcSEcCtD
Rizatriptan—Oedema—Donepezil—Alzheimer's disease	0.000922	0.00173	CcSEcCtD
Rizatriptan—Vertigo—Memantine—Alzheimer's disease	0.000922	0.00173	CcSEcCtD
Rizatriptan—Syncope—Memantine—Alzheimer's disease	0.00092	0.00173	CcSEcCtD
Rizatriptan—Shock—Donepezil—Alzheimer's disease	0.000907	0.0017	CcSEcCtD
Rizatriptan—Palpitations—Memantine—Alzheimer's disease	0.000907	0.0017	CcSEcCtD
Rizatriptan—Nervous system disorder—Donepezil—Alzheimer's disease	0.000905	0.0017	CcSEcCtD
Rizatriptan—Vertigo—Rivastigmine—Alzheimer's disease	0.000902	0.00169	CcSEcCtD
Rizatriptan—Loss of consciousness—Memantine—Alzheimer's disease	0.000902	0.00169	CcSEcCtD
Rizatriptan—Syncope—Rivastigmine—Alzheimer's disease	0.0009	0.00169	CcSEcCtD
Rizatriptan—Cough—Memantine—Alzheimer's disease	0.000895	0.00168	CcSEcCtD
Rizatriptan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000892	0.00167	CcSEcCtD
Rizatriptan—Convulsion—Memantine—Alzheimer's disease	0.000889	0.00167	CcSEcCtD
Rizatriptan—Palpitations—Rivastigmine—Alzheimer's disease	0.000887	0.00166	CcSEcCtD
Rizatriptan—Hypertension—Memantine—Alzheimer's disease	0.000886	0.00166	CcSEcCtD
Rizatriptan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000882	0.00166	CcSEcCtD
Rizatriptan—Anorexia—Donepezil—Alzheimer's disease	0.000879	0.00165	CcSEcCtD
Rizatriptan—Hypersensitivity—Galantamine—Alzheimer's disease	0.000877	0.00165	CcSEcCtD
Rizatriptan—Cough—Rivastigmine—Alzheimer's disease	0.000876	0.00164	CcSEcCtD
Rizatriptan—Arthralgia—Memantine—Alzheimer's disease	0.000874	0.00164	CcSEcCtD
Rizatriptan—Myalgia—Memantine—Alzheimer's disease	0.000874	0.00164	CcSEcCtD
Rizatriptan—Chest pain—Memantine—Alzheimer's disease	0.000874	0.00164	CcSEcCtD
Rizatriptan—Anxiety—Memantine—Alzheimer's disease	0.000871	0.00163	CcSEcCtD
Rizatriptan—Convulsion—Rivastigmine—Alzheimer's disease	0.00087	0.00163	CcSEcCtD
Rizatriptan—Hypertension—Rivastigmine—Alzheimer's disease	0.000867	0.00163	CcSEcCtD
Rizatriptan—Discomfort—Memantine—Alzheimer's disease	0.000863	0.00162	CcSEcCtD
Rizatriptan—Myalgia—Rivastigmine—Alzheimer's disease	0.000855	0.0016	CcSEcCtD
Rizatriptan—Chest pain—Rivastigmine—Alzheimer's disease	0.000855	0.0016	CcSEcCtD
Rizatriptan—Arthralgia—Rivastigmine—Alzheimer's disease	0.000855	0.0016	CcSEcCtD
Rizatriptan—Dry mouth—Memantine—Alzheimer's disease	0.000854	0.0016	CcSEcCtD
Rizatriptan—Asthenia—Galantamine—Alzheimer's disease	0.000854	0.0016	CcSEcCtD
Rizatriptan—Anxiety—Rivastigmine—Alzheimer's disease	0.000852	0.0016	CcSEcCtD
Rizatriptan—Confusional state—Memantine—Alzheimer's disease	0.000844	0.00158	CcSEcCtD
Rizatriptan—Discomfort—Rivastigmine—Alzheimer's disease	0.000844	0.00158	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00084	0.00158	CcSEcCtD
Rizatriptan—Oedema—Memantine—Alzheimer's disease	0.000838	0.00157	CcSEcCtD
Rizatriptan—Dry mouth—Rivastigmine—Alzheimer's disease	0.000836	0.00157	CcSEcCtD
Rizatriptan—Insomnia—Donepezil—Alzheimer's disease	0.000834	0.00157	CcSEcCtD
Rizatriptan—Paraesthesia—Donepezil—Alzheimer's disease	0.000828	0.00155	CcSEcCtD
Rizatriptan—Confusional state—Rivastigmine—Alzheimer's disease	0.000826	0.00155	CcSEcCtD
Rizatriptan—Shock—Memantine—Alzheimer's disease	0.000824	0.00155	CcSEcCtD
Rizatriptan—Dyspnoea—Donepezil—Alzheimer's disease	0.000822	0.00154	CcSEcCtD
Rizatriptan—Nervous system disorder—Memantine—Alzheimer's disease	0.000821	0.00154	CcSEcCtD
Rizatriptan—Somnolence—Donepezil—Alzheimer's disease	0.00082	0.00154	CcSEcCtD
Rizatriptan—Oedema—Rivastigmine—Alzheimer's disease	0.000819	0.00154	CcSEcCtD
Rizatriptan—Tachycardia—Memantine—Alzheimer's disease	0.000817	0.00153	CcSEcCtD
Rizatriptan—Diarrhoea—Galantamine—Alzheimer's disease	0.000814	0.00153	CcSEcCtD
Rizatriptan—Dyspepsia—Donepezil—Alzheimer's disease	0.000812	0.00152	CcSEcCtD
Rizatriptan—Hyperhidrosis—Memantine—Alzheimer's disease	0.00081	0.00152	CcSEcCtD
Rizatriptan—Shock—Rivastigmine—Alzheimer's disease	0.000806	0.00151	CcSEcCtD
Rizatriptan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000803	0.00151	CcSEcCtD
Rizatriptan—Decreased appetite—Donepezil—Alzheimer's disease	0.000802	0.0015	CcSEcCtD
Rizatriptan—Tachycardia—Rivastigmine—Alzheimer's disease	0.0008	0.0015	CcSEcCtD
Rizatriptan—Anorexia—Memantine—Alzheimer's disease	0.000798	0.0015	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000796	0.00149	CcSEcCtD
Rizatriptan—Fatigue—Donepezil—Alzheimer's disease	0.000795	0.00149	CcSEcCtD
Rizatriptan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000792	0.00149	CcSEcCtD
Rizatriptan—Pain—Donepezil—Alzheimer's disease	0.000789	0.00148	CcSEcCtD
Rizatriptan—Constipation—Donepezil—Alzheimer's disease	0.000789	0.00148	CcSEcCtD
Rizatriptan—Dizziness—Galantamine—Alzheimer's disease	0.000787	0.00148	CcSEcCtD
Rizatriptan—Anorexia—Rivastigmine—Alzheimer's disease	0.000781	0.00147	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000763	0.00143	CcSEcCtD
Rizatriptan—Feeling abnormal—Donepezil—Alzheimer's disease	0.00076	0.00143	CcSEcCtD
Rizatriptan—Insomnia—Memantine—Alzheimer's disease	0.000757	0.00142	CcSEcCtD
Rizatriptan—Vomiting—Galantamine—Alzheimer's disease	0.000757	0.00142	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000754	0.00142	CcSEcCtD
Rizatriptan—Paraesthesia—Memantine—Alzheimer's disease	0.000752	0.00141	CcSEcCtD
Rizatriptan—Rash—Galantamine—Alzheimer's disease	0.00075	0.00141	CcSEcCtD
Rizatriptan—Dermatitis—Galantamine—Alzheimer's disease	0.00075	0.00141	CcSEcCtD
Rizatriptan—Dyspnoea—Memantine—Alzheimer's disease	0.000747	0.0014	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000746	0.0014	CcSEcCtD
Rizatriptan—Headache—Galantamine—Alzheimer's disease	0.000746	0.0014	CcSEcCtD
Rizatriptan—Somnolence—Memantine—Alzheimer's disease	0.000745	0.0014	CcSEcCtD
Rizatriptan—Insomnia—Rivastigmine—Alzheimer's disease	0.000741	0.00139	CcSEcCtD
Rizatriptan—Dyspepsia—Memantine—Alzheimer's disease	0.000737	0.00138	CcSEcCtD
Rizatriptan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000736	0.00138	CcSEcCtD
Rizatriptan—Urticaria—Donepezil—Alzheimer's disease	0.000733	0.00137	CcSEcCtD
Rizatriptan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00073	0.00137	CcSEcCtD
Rizatriptan—Abdominal pain—Donepezil—Alzheimer's disease	0.000729	0.00137	CcSEcCtD
Rizatriptan—Body temperature increased—Donepezil—Alzheimer's disease	0.000729	0.00137	CcSEcCtD
Rizatriptan—Somnolence—Rivastigmine—Alzheimer's disease	0.000728	0.00137	CcSEcCtD
Rizatriptan—Decreased appetite—Memantine—Alzheimer's disease	0.000728	0.00137	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000723	0.00136	CcSEcCtD
Rizatriptan—Fatigue—Memantine—Alzheimer's disease	0.000722	0.00135	CcSEcCtD
Rizatriptan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000721	0.00135	CcSEcCtD
Rizatriptan—Pain—Memantine—Alzheimer's disease	0.000716	0.00134	CcSEcCtD
Rizatriptan—Constipation—Memantine—Alzheimer's disease	0.000716	0.00134	CcSEcCtD
Rizatriptan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000712	0.00134	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000707	0.00133	CcSEcCtD
Rizatriptan—Nausea—Galantamine—Alzheimer's disease	0.000707	0.00133	CcSEcCtD
Rizatriptan—Fatigue—Rivastigmine—Alzheimer's disease	0.000706	0.00133	CcSEcCtD
Rizatriptan—Constipation—Rivastigmine—Alzheimer's disease	0.000701	0.00131	CcSEcCtD
Rizatriptan—Pain—Rivastigmine—Alzheimer's disease	0.000701	0.00131	CcSEcCtD
Rizatriptan—Feeling abnormal—Memantine—Alzheimer's disease	0.00069	0.00129	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000685	0.00128	CcSEcCtD
Rizatriptan—Hypersensitivity—Donepezil—Alzheimer's disease	0.00068	0.00128	CcSEcCtD
Rizatriptan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000675	0.00127	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00067	0.00126	CcSEcCtD
Rizatriptan—Urticaria—Memantine—Alzheimer's disease	0.000665	0.00125	CcSEcCtD
Rizatriptan—Body temperature increased—Memantine—Alzheimer's disease	0.000662	0.00124	CcSEcCtD
Rizatriptan—Abdominal pain—Memantine—Alzheimer's disease	0.000662	0.00124	CcSEcCtD
Rizatriptan—Asthenia—Donepezil—Alzheimer's disease	0.000662	0.00124	CcSEcCtD
Rizatriptan—Pruritus—Donepezil—Alzheimer's disease	0.000653	0.00122	CcSEcCtD
Rizatriptan—Urticaria—Rivastigmine—Alzheimer's disease	0.000651	0.00122	CcSEcCtD
Rizatriptan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000648	0.00122	CcSEcCtD
Rizatriptan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000648	0.00122	CcSEcCtD
Rizatriptan—Diarrhoea—Donepezil—Alzheimer's disease	0.000631	0.00118	CcSEcCtD
Rizatriptan—Hypersensitivity—Memantine—Alzheimer's disease	0.000617	0.00116	CcSEcCtD
Rizatriptan—Dizziness—Donepezil—Alzheimer's disease	0.00061	0.00114	CcSEcCtD
Rizatriptan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000604	0.00113	CcSEcCtD
Rizatriptan—Asthenia—Memantine—Alzheimer's disease	0.000601	0.00113	CcSEcCtD
Rizatriptan—Pruritus—Memantine—Alzheimer's disease	0.000593	0.00111	CcSEcCtD
Rizatriptan—Asthenia—Rivastigmine—Alzheimer's disease	0.000588	0.0011	CcSEcCtD
Rizatriptan—Vomiting—Donepezil—Alzheimer's disease	0.000586	0.0011	CcSEcCtD
Rizatriptan—Rash—Donepezil—Alzheimer's disease	0.000582	0.00109	CcSEcCtD
Rizatriptan—Dermatitis—Donepezil—Alzheimer's disease	0.000581	0.00109	CcSEcCtD
Rizatriptan—Pruritus—Rivastigmine—Alzheimer's disease	0.00058	0.00109	CcSEcCtD
Rizatriptan—Headache—Donepezil—Alzheimer's disease	0.000578	0.00108	CcSEcCtD
Rizatriptan—Diarrhoea—Memantine—Alzheimer's disease	0.000573	0.00108	CcSEcCtD
Rizatriptan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000561	0.00105	CcSEcCtD
Rizatriptan—Dizziness—Memantine—Alzheimer's disease	0.000554	0.00104	CcSEcCtD
Rizatriptan—Nausea—Donepezil—Alzheimer's disease	0.000548	0.00103	CcSEcCtD
Rizatriptan—Dizziness—Rivastigmine—Alzheimer's disease	0.000542	0.00102	CcSEcCtD
Rizatriptan—Vomiting—Memantine—Alzheimer's disease	0.000532	0.000999	CcSEcCtD
Rizatriptan—Rash—Memantine—Alzheimer's disease	0.000528	0.000991	CcSEcCtD
Rizatriptan—Dermatitis—Memantine—Alzheimer's disease	0.000528	0.00099	CcSEcCtD
Rizatriptan—Headache—Memantine—Alzheimer's disease	0.000525	0.000984	CcSEcCtD
Rizatriptan—Vomiting—Rivastigmine—Alzheimer's disease	0.000521	0.000977	CcSEcCtD
Rizatriptan—Rash—Rivastigmine—Alzheimer's disease	0.000517	0.000969	CcSEcCtD
Rizatriptan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000516	0.000968	CcSEcCtD
Rizatriptan—Headache—Rivastigmine—Alzheimer's disease	0.000513	0.000963	CcSEcCtD
Rizatriptan—Nausea—Memantine—Alzheimer's disease	0.000497	0.000933	CcSEcCtD
Rizatriptan—Nausea—Rivastigmine—Alzheimer's disease	0.000487	0.000913	CcSEcCtD
Rizatriptan—MAOA—Metabolism—PTGS1—Alzheimer's disease	6.6e-05	0.00025	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—LPL—Alzheimer's disease	6.56e-05	0.000249	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCR5—Alzheimer's disease	6.54e-05	0.000248	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	6.53e-05	0.000248	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	6.53e-05	0.000248	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MEF2C—Alzheimer's disease	6.5e-05	0.000247	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CRH—Alzheimer's disease	6.49e-05	0.000246	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP2D6—Alzheimer's disease	6.47e-05	0.000245	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	6.45e-05	0.000245	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCR5—Alzheimer's disease	6.41e-05	0.000243	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HTR2A—Alzheimer's disease	6.4e-05	0.000243	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PRKCG—Alzheimer's disease	6.38e-05	0.000242	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NPS—Alzheimer's disease	6.29e-05	0.000238	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HTR2A—Alzheimer's disease	6.27e-05	0.000238	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PPP3CA—Alzheimer's disease	6.26e-05	0.000237	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NGF—Alzheimer's disease	6.21e-05	0.000236	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—F2—Alzheimer's disease	6.18e-05	0.000234	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTK2B—Alzheimer's disease	6.17e-05	0.000234	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NPS—Alzheimer's disease	6.16e-05	0.000233	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—BCHE—Alzheimer's disease	6.13e-05	0.000233	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PPP3CA—Alzheimer's disease	6.13e-05	0.000232	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	6.11e-05	0.000232	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—F2—Alzheimer's disease	6.05e-05	0.00023	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCR5—Alzheimer's disease	6.04e-05	0.000229	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTK2B—Alzheimer's disease	6.04e-05	0.000229	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GAB2—Alzheimer's disease	6e-05	0.000227	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NTRK2—Alzheimer's disease	6e-05	0.000227	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SST—Alzheimer's disease	6e-05	0.000227	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CALM1—Alzheimer's disease	5.97e-05	0.000227	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GSK3A—Alzheimer's disease	5.94e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HTR2A—Alzheimer's disease	5.91e-05	0.000224	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SST—Alzheimer's disease	5.87e-05	0.000223	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GAB2—Alzheimer's disease	5.87e-05	0.000223	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NTRK2—Alzheimer's disease	5.87e-05	0.000223	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CALM1—Alzheimer's disease	5.85e-05	0.000222	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APP—Alzheimer's disease	5.84e-05	0.000222	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLD3—Alzheimer's disease	5.83e-05	0.000221	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.83e-05	0.000221	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GSK3A—Alzheimer's disease	5.82e-05	0.000221	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PLCB1—Alzheimer's disease	5.79e-05	0.000219	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.76e-05	0.000219	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	5.75e-05	0.000218	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APP—Alzheimer's disease	5.72e-05	0.000217	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	5.67e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—F2—Alzheimer's disease	5.61e-05	0.000213	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ABCA1—Alzheimer's disease	5.61e-05	0.000213	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	5.59e-05	0.000212	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	5.57e-05	0.000211	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CALM1—Alzheimer's disease	5.52e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PLCB1—Alzheimer's disease	5.51e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—APOE—Alzheimer's disease	5.5e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—LEP—Alzheimer's disease	5.5e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—F2—Alzheimer's disease	5.5e-05	0.000208	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.46e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CAV1—Alzheimer's disease	5.45e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PLCB1—Alzheimer's disease	5.4e-05	0.000205	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	5.38e-05	0.000204	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	5.37e-05	0.000204	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.26e-05	0.000199	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ESR1—Alzheimer's disease	5.25e-05	0.000199	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ND1—Alzheimer's disease	5.2e-05	0.000197	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—F2—Alzheimer's disease	5.18e-05	0.000197	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	5.15e-05	0.000195	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NGFR—Alzheimer's disease	5.15e-05	0.000195	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	5.13e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CREB1—Alzheimer's disease	5.11e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	5.1e-05	0.000193	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.08e-05	0.000193	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOTCH1—Alzheimer's disease	5.07e-05	0.000192	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NGFR—Alzheimer's disease	5.04e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADAM10—Alzheimer's disease	5.03e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CREB1—Alzheimer's disease	5.01e-05	0.00019	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCL2—Alzheimer's disease	5e-05	0.00019	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	4.95e-05	0.000188	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADAM10—Alzheimer's disease	4.92e-05	0.000187	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCL2—Alzheimer's disease	4.9e-05	0.000186	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	4.88e-05	0.000185	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	4.83e-05	0.000183	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—HMOX1—Alzheimer's disease	4.81e-05	0.000183	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	4.78e-05	0.000181	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GSK3B—Alzheimer's disease	4.76e-05	0.000181	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—S100B—Alzheimer's disease	4.75e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CREB1—Alzheimer's disease	4.72e-05	0.000179	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—INS—Alzheimer's disease	4.7e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	4.69e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	4.67e-05	0.000177	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—S100B—Alzheimer's disease	4.65e-05	0.000176	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.65e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCL2—Alzheimer's disease	4.62e-05	0.000175	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	4.61e-05	0.000175	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	4.6e-05	0.000174	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF1—Alzheimer's disease	4.54e-05	0.000172	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF2—Alzheimer's disease	4.53e-05	0.000172	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	4.47e-05	0.00017	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SST—Alzheimer's disease	4.47e-05	0.00017	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	4.47e-05	0.00017	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	4.46e-05	0.000169	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	4.43e-05	0.000168	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF2—Alzheimer's disease	4.43e-05	0.000168	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—LPL—Alzheimer's disease	4.4e-05	0.000167	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1R—Alzheimer's disease	4.38e-05	0.000166	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APP—Alzheimer's disease	4.36e-05	0.000165	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1R—Alzheimer's disease	4.28e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LPL—Alzheimer's disease	4.19e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	4.19e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MEF2C—Alzheimer's disease	4.16e-05	0.000158	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOS3—Alzheimer's disease	4.12e-05	0.000156	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	4.11e-05	0.000156	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LPL—Alzheimer's disease	4.11e-05	0.000156	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PRKCG—Alzheimer's disease	4.08e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MEF2C—Alzheimer's disease	4.07e-05	0.000154	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4e-05	0.000152	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PRKCG—Alzheimer's disease	3.99e-05	0.000151	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NGF—Alzheimer's disease	3.97e-05	0.000151	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MTHFR—Alzheimer's disease	3.96e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NGF—Alzheimer's disease	3.89e-05	0.000148	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCR5—Alzheimer's disease	3.86e-05	0.000147	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	3.84e-05	0.000146	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	3.81e-05	0.000145	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCR5—Alzheimer's disease	3.78e-05	0.000144	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR2A—Alzheimer's disease	3.78e-05	0.000143	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	3.75e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	3.73e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR2A—Alzheimer's disease	3.7e-05	0.00014	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CALM1—Alzheimer's disease	3.7e-05	0.00014	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOE—Alzheimer's disease	3.69e-05	0.00014	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CAV1—Alzheimer's disease	3.66e-05	0.000139	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.65e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	3.54e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—Alzheimer's disease	3.53e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CALM1—Alzheimer's disease	3.53e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOE—Alzheimer's disease	3.52e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LEP—Alzheimer's disease	3.52e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—Alzheimer's disease	3.5e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CAV1—Alzheimer's disease	3.48e-05	0.000132	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—Alzheimer's disease	3.47e-05	0.000132	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CALM1—Alzheimer's disease	3.45e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LEP—Alzheimer's disease	3.44e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOE—Alzheimer's disease	3.44e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CAV1—Alzheimer's disease	3.41e-05	0.000129	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	3.38e-05	0.000128	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ESR1—Alzheimer's disease	3.36e-05	0.000127	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CHAT—Alzheimer's disease	3.35e-05	0.000127	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TPI1—Alzheimer's disease	3.35e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—F2—Alzheimer's disease	3.32e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ESR1—Alzheimer's disease	3.29e-05	0.000125	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	3.26e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—F2—Alzheimer's disease	3.25e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH1—Alzheimer's disease	3.24e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK8—Alzheimer's disease	3.21e-05	0.000122	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARG—Alzheimer's disease	3.21e-05	0.000122	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MAOB—Alzheimer's disease	3.21e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—Alzheimer's disease	3.21e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH1—Alzheimer's disease	3.18e-05	0.000121	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—INS—Alzheimer's disease	3.15e-05	0.00012	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	3.13e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	3.1e-05	0.000118	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	3.09e-05	0.000117	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.06e-05	0.000116	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GSK3B—Alzheimer's disease	3.04e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	3.04e-05	0.000115	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.03e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CREB1—Alzheimer's disease	3.02e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—INS—Alzheimer's disease	3e-05	0.000114	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—A2M—Alzheimer's disease	2.98e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GSK3B—Alzheimer's disease	2.98e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—Alzheimer's disease	2.97e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	2.96e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CREB1—Alzheimer's disease	2.96e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL2—Alzheimer's disease	2.96e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—INS—Alzheimer's disease	2.94e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1—Alzheimer's disease	2.91e-05	0.00011	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL2—Alzheimer's disease	2.89e-05	0.00011	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	2.88e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1—Alzheimer's disease	2.84e-05	0.000108	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	2.82e-05	0.000107	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NOS3—Alzheimer's disease	2.76e-05	0.000105	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—Alzheimer's disease	2.72e-05	0.000103	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.66e-05	0.000101	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOS3—Alzheimer's disease	2.63e-05	9.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	2.63e-05	9.98e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	2.62e-05	9.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	2.62e-05	9.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	2.6e-05	9.86e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ACHE—Alzheimer's disease	2.6e-05	9.85e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOS3—Alzheimer's disease	2.58e-05	9.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.57e-05	9.73e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—Alzheimer's disease	2.53e-05	9.59e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	2.5e-05	9.5e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—F2—Alzheimer's disease	2.47e-05	9.38e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.43e-05	9.23e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.43e-05	9.23e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.42e-05	9.18e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.39e-05	9.05e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.27e-05	8.61e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.26e-05	8.58e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	2.26e-05	8.56e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	2.25e-05	8.54e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—Alzheimer's disease	2.24e-05	8.5e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—INS—Alzheimer's disease	2.24e-05	8.5e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	2.24e-05	8.48e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	2.22e-05	8.43e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.21e-05	8.38e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	2.2e-05	8.36e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	2.19e-05	8.31e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	2.18e-05	8.25e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	2.17e-05	8.22e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.13e-05	8.1e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.09e-05	7.94e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.07e-05	7.85e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	2.06e-05	7.8e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—Alzheimer's disease	2.05e-05	7.78e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	2.05e-05	7.77e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.01e-05	7.63e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.01e-05	7.61e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	1.96e-05	7.45e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.9e-05	7.2e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—Alzheimer's disease	1.89e-05	7.18e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.86e-05	7.05e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.78e-05	6.76e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.77e-05	6.73e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.74e-05	6.61e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.71e-05	6.47e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.68e-05	6.39e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.67e-05	6.33e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.66e-05	6.29e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.62e-05	6.16e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.53e-05	5.81e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.53e-05	5.8e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.46e-05	5.54e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.43e-05	5.44e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.42e-05	5.37e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.4e-05	5.33e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.37e-05	5.18e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.36e-05	5.16e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.35e-05	5.11e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.31e-05	4.98e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.3e-05	4.93e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.29e-05	4.87e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—Alzheimer's disease	1.27e-05	4.82e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.21e-05	4.59e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.19e-05	4.5e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.19e-05	4.5e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—INS—Alzheimer's disease	1.16e-05	4.41e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.07e-05	4.06e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.02e-05	3.87e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.79e-06	3.71e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	9.32e-06	3.54e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	9.03e-06	3.43e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.69e-06	1.78e-05	CbGpPWpGaD
